These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review. Miziołek B; Bergler-Czop B; Stańkowska A; Brzezińska-Wcisło L Cutan Ocul Toxicol; 2017 Mar; 36(1):77-84. PubMed ID: 27160965 [TBL] [Abstract][Full Text] [Related]
8. [Lupus nephritis treatment]. Santos-Araújo C; Pestana M Acta Med Port; 2008; 21(3):259-72. PubMed ID: 18674418 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. Choi CB; Won S; Bae SC Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881 [TBL] [Abstract][Full Text] [Related]
10. Update on the treatment of lupus nephritis. Hogan J; Appel GB Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):224-30. PubMed ID: 23328501 [TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Vigna-Perez M; Hernández-Castro B; Paredes-Saharopulos O; Portales-Pérez D; Baranda L; Abud-Mendoza C; González-Amaro R Arthritis Res Ther; 2006; 8(3):R83. PubMed ID: 16677395 [TBL] [Abstract][Full Text] [Related]
12. Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis. Yung S; Chan TM Clin Immunol; 2017 Dec; 185():40-50. PubMed ID: 27612436 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of systemic lupus erythematosus: myths, certainties and doubts]. Ruiz-Irastorza G; Danza A; Khamashta M Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892 [TBL] [Abstract][Full Text] [Related]
14. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy. Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545 [TBL] [Abstract][Full Text] [Related]
15. Single-dose rituximab in refractory lupus nephritis. Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250 [TBL] [Abstract][Full Text] [Related]
16. Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside. Obrișcă B; Sorohan B; Tuță L; Ismail G Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916456 [TBL] [Abstract][Full Text] [Related]
17. Pediatric Lupus Nephritis-Review of Literature. Thakur N; Rai N; Batra P Curr Rheumatol Rev; 2017; 13(1):29-36. PubMed ID: 27041086 [TBL] [Abstract][Full Text] [Related]
19. Lupus nephritis. Sauter M; Anders HJ Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686 [TBL] [Abstract][Full Text] [Related]
20. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]